Natural sea salt in diet ameliorates better protection compared to table salt in the doxorubicin-induced cardiac remodeling

References

• Kaptoge S, Pennells L, De Bacquer D, et al. World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions. Lancet Glob Health. 2019;7(10):e1332–e1345.
   PubMed Web of Science ®Google Scholar
• Verdecchia P, et al. Sudden cardiac death in hypertensive patients. Hypertension. 2019;73(5):1071–1078.
   PubMed Web of Science ®Google Scholar
• Al-Orabi AS, et al. Levocetirizine and amlodipine restores hepato-cardiac function in the forced swim-induced cardiac remodelling Rat model. J Pharmaceut Res Int. 2018: 1–10.
   Web of Science ®Google Scholar
• Cokkinos, D.V., Cardiac remodeling: the course toward heart failure–I. General concepts. In Myocardial preservation. Springer; 2019. p. 215–245.
   Google Scholar
• Matsumura K, et al. Cardiac rupture due to reinfarction in the early phase of apical myocardial infarction. Int Heart J. 2019;60(4):974–978.
   PubMed Web of Science ®Google Scholar
• Gelosa P, et al. Drug repurposing in cardiovascular diseases: opportunity or hopeless dream? Biochem Pharmacol. 2020;113894.
   Google Scholar
• Skjødt MK, Frost M, Abrahamsen B. Side effects of drugs for osteoporosis and metastatic bone disease. Br J Clin Pharmacol. 2019;85(6):1063–1071.
   PubMed Web of Science ®Google Scholar
• Ha SK. Dietary salt intake and hypertension. Electrolytes Blood Press. 2014;12(1):7–18.
   PubMedGoogle Scholar
• Choi HY, Park HC, Ha SK. Salt sensitivity and hypertension: a paradigm shift from kidney malfunction to vascular endothelial dysfunction. Electrolytes Blood Press. 2015;13(1):7–16.
   PubMedGoogle Scholar
• Rust P, Ekmekcioglu C. Impact of salt intake on the pathogenesis and treatment of hypertension. In Hypertension: from basic research to clinical practice. Springer; 2016. p. 61–84.
   Google Scholar
• Lackland DT, Weber MA. Global burden of cardiovascular disease and stroke: hypertension at the core. Can J Cardiol. 2015;31(5):569–571.
   PubMed Web of Science ®Google Scholar
• Doukky R, et al. Impact of dietary sodium restriction on heart failure outcomes. JACC: Heart Failure. 2016;4(1):24–35.
   PubMed Web of Science ®Google Scholar
• Humalda JK, Navis G. Dietary sodium restriction: a neglected therapeutic opportunity in chronic kidney disease. Curr Opin Nephrol Hypertens. 2014;23(6):533.
   PubMed Web of Science ®Google Scholar
• Trieu K, et al. Salt reduction initiatives around the world – a systematic review of progress towards the global target. PLoS One. 2015;10(7):e0130247.
   PubMed Web of Science ®Google Scholar
• Mente A, et al. Urinary sodium excretion, blood pressure, cardiovascular disease, and mortality: a community-level prospective epidemiological cohort study. Lancet. 2018;392(10146):496–506.
   PubMed Web of Science ®Google Scholar
• Wang J, et al. Long-term low salt diet increases blood pressure by activation of the renin-angiotensin and sympathetic nervous systems. Clin Exp Hypertens. 2019;41(8):739–746.
   PubMed Web of Science ®Google Scholar
• He FJ, Burnier M, MacGregor GA. Nutrition in cardiovascular disease: salt in hypertension and heart failure. Eur Heart J. 2011;32(24):3073–3080.
   PubMed Web of Science ®Google Scholar
• Klein L, et al. Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: results from the outcomes of a prospective trial of intravenous milrinone for exacerbations of chronic heart failure (OPTIME-CHF) study. Circulation. 2005;111(19):2454–2460.
   PubMed Web of Science ®Google Scholar
• Schroten NF, et al. Effect of additive renin inhibition with aliskiren on renal blood flow in patients with chronic heart failure and renal dysfunction (additive renin inhibition with aliskiren on renal blood flow and neurohormonal activation in patients with chronic heart failure and renal dysfunction). Am Heart J. 2015;169(5):693–701.e3.
   PubMed Web of Science ®Google Scholar
• Carvalho FS, et al. Doxorubicin-induced cardiotoxicity: from bioenergetic failure and cell death to cardiomyopathy. Med Res Rev. 2014;34(1):106–135.
   PubMed Web of Science ®Google Scholar
• Timm KN, et al. Early detection of doxorubicin-induced cardiotoxicity in rats by its cardiac metabolic signature assessed with hyperpolarized MRI. Commun Biol. 2020;3(1):1–10.
   PubMed Web of Science ®Google Scholar
• Forechi L, et al. Effects of high and low salt intake on left ventricular remodeling after myocardial infarction in normotensive rats. J Am Soc Hypertens. 2015;9(2):77–85.
   PubMed Web of Science ®Google Scholar
• Ikonomidis I, et al. Multimarker approach in cardiovascular risk prediction. Dis Markers. 2009;26(5, 6):273–285.
   PubMed Web of Science ®Google Scholar
• Dastan F, et al. The potential effect of intravenous calcitriol on the ischemia-reperfusion injury and inflammatory biomarkers in patients following percutaneous coronary intervention (PCI). Iran J Pharm Res. 2019;18(Special Issue):282–290.
   PubMedGoogle Scholar
• Hasan KMM, Tamanna N, Haque MA. Biochemical and histopathological profiling of Wistar rat treated with Brassica napus as a supplementary feed. Food Sci Hum Wellness. 2018;7(1):77–82.
   Google Scholar
• Wang J, et al. Proline improves cardiac remodeling following myocardial infarction and attenuates cardiomyocyte apoptosis via redox regulation. Biochem Pharmacol. 2020: 114065.
   PubMed Web of Science ®Google Scholar
• Mendes AS, et al. Verapamil decreases calpain-1 and matrix metalloproteinase-2 activities and improves hypertension-induced hypertrophic cardiac remodeling in rats. Life Sci. 2020;244:117153.
   PubMed Web of Science ®Google Scholar
• Puato M, et al. Lipid profile, inflammatory cytokines and vascular remodeling in dyslipidemic subjects treated with nutraceuticals. J Hypertens. 2019;37:e187.
   PubMed Web of Science ®Google Scholar
• Yap J, et al. Association of diabetes mellitus on cardiac remodeling, quality of life, and clinical outcomes in heart failure with reduced and preserved ejection fraction. J Am Heart Assoc. 2019;8(17):e013114.
   PubMed Web of Science ®Google Scholar
• Piché M-E, Tchernof A, Després J-P. Obesity phenotypes, diabetes, and cardiovascular diseases. Circ Res. 2020;126(11):1477–1500.
   PubMed Web of Science ®Google Scholar
• Khoramdad M, et al. Association between passive smoking and cardiovascular disease: a systematic review and meta-analysis. IUBMB Life. 2020;72(4):677–686.
   PubMed Web of Science ®Google Scholar
• Lampuré A, et al. Relationship between sensory liking for fat, sweet or salt and cardiometabolic diseases: mediating effects of diet and weight status. Eur J Nutr. 2020;59(1):249–261.
   PubMed Web of Science ®Google Scholar
• Khan MS, Jones DW, Butler J. Salt, no salt, or less salt for patients with heart failure? Am J Med. 2020;133(1):32–38.
   PubMed Web of Science ®Google Scholar
• Catena C, et al. Salt, aldosterone, and parathyroid hormone: what is the relevance for organ damage? Int J Endocrinol. 2017;2017.
   PubMed Web of Science ®Google Scholar
• Cole NI, et al. The association between serum sodium concentration, hypertension and primary cardiovascular events: a retrospective cohort study. J Hum Hypertens. 2019;33(1):69–77.
   PubMed Web of Science ®Google Scholar
• Cheng P, et al. Xin-Ji-Er-Kang alleviates myocardial infarction-induced cardiovascular remodeling in rats by inhibiting endothelial dysfunction. BioMed Res Int. 2019;2019.
   Web of Science ®Google Scholar
• Kang HJ, et al. Low salt and low calorie diet does not reduce more body fat than same calorie diet: a randomized controlled study. Oncotarget. 2018;9(9):8521.
   PubMedGoogle Scholar
• Oh H, et al. Low salt diet and insulin resistance. Clin Nutr Res. 2016;5(1):1–6.
   PubMedGoogle Scholar
• Baqar S, et al. Effect of salt supplementation on sympathetic activity and endothelial function in salt-sensitive type 2 diabetes. J Clin Endocrinol Metab. 2020;105(4):e1187–e1200.
   Web of Science ®Google Scholar
• de Borst MH, Navis G. Sodium intake, RAAS-blockade and progressive renal disease. Pharmacol Res. 2016;107:344–351.
   PubMed Web of Science ®Google Scholar
• Fusco FB, et al. Low-sodium diet induces atherogenesis regardless of lowering blood pressure in hypertensive hyperlipidemic mice. PLoS One. 2017;12(5):e0177086.
   PubMed Web of Science ®Google Scholar
• Savic-Radojevic A, Pljesa-Ercegovac M, Matic M, et al. Novel biomarkers of heart failure. Adv Clin Chem. 2017;79:93–152.
   PubMed Web of Science ®Google Scholar
• Shah S, et al. EGFR tyrosine kinase inhibition decreases cardiac remodeling and SERCA2a/NCX1 depletion in streptozotocin induced cardiomyopathy in C57/BL6 mice. Life Sci. 2018;210:29–39.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wei W, Shilova V, et al. Monoclonal antibody to marinobufagenin downregulates TGFß profibrotic signaling in left ventricle and kidney and reduces tissue remodeling in salt-sensitive hypertension. J Am Heart Assoc. 2019;8(20):e012138.
   PubMed Web of Science ®Google Scholar
• Chirakarnjanakorn S, et al. Cardiovascular impact in patients undergoing maintenance hemodialysis: clinical management considerations. Int J Cardiol. 2017;232:12–23.
   PubMed Web of Science ®Google Scholar
• Gafane-Matemane LF, et al. Relation of the renin–angiotensin–aldosterone system with potential cardiac injury and remodelling: the SABPA study. Blood Press. 2020;29(1):31–38.
   PubMed Web of Science ®Google Scholar
• Reyes S, et al. Novel cardiac intracrine mechanisms based on Ang-(1-12)/chymase axis require a revision of therapeutic approaches in human heart disease. Curr Hypertens Rep. 2017;19(2):16.
   PubMed Web of Science ®Google Scholar
• Rosa G, et al. High salt intake during puberty leads to cardiac remodelling and baroreflex impairment in lean and obese male Wistar rats. Br J Nutr. 2020;123(6):642–651.
   PubMed Web of Science ®Google Scholar
• Allen LA, et al. High salt diet impairs cerebral blood flow regulation via salt-induced angiotensin II suppression. Microcirculation. 2019;26(3):e12518.
   PubMed Web of Science ®Google Scholar
• Butt N, et al. Pentraxin 3 in primary percutaneous coronary intervention for ST elevation myocardial infarction is associated with early irreversible myocardial damage: kinetic profile, relationship to interleukin 6 and infarct size. Eur Heart J Acute Cardiovasc Care. 2020;9(4):302–312.
   PubMed Web of Science ®Google Scholar
• Ohtsuka T, et al. Relation of circulating interleukin-6 to left ventricular remodeling in patients with reperfused anterior myocardial infarction. Clin Cardiol. 2004;27(7):417–420.
   PubMed Web of Science ®Google Scholar
• Bartekova M, et al. Role of cytokines and inflammation in heart function during health and disease. Heart Fail Rev. 2018;23(5):733–758.
   PubMed Web of Science ®Google Scholar
• Altara R, et al. CXCL10 is a circulating inflammatory marker in patients with advanced heart failure: a pilot study. J Cardiovasc Transl Res. 2016;9(4):302–314.
   PubMed Web of Science ®Google Scholar
• Sikka G, et al. Interleukin 10 knockout frail mice develop cardiac and vascular dysfunction with increased age. Exp Gerontol. 2013;48(2):128–135.
   PubMed Web of Science ®Google Scholar
• Yue Y, et al. Interleukin-10 deficiency alters endothelial progenitor cell–derived exosome reparative effect on myocardial repair via integrin-linked kinase enrichment. Circ Res. 2020;126(3):315–329.
   PubMed Web of Science ®Google Scholar
• Berk BC, Fujiwara K, Lehoux S. ECM remodeling in hypertensive heart disease. J Clin Invest. 2007;117(3):568–575.
   PubMed Web of Science ®Google Scholar
• Leonard BL, Smaill BH, LeGrice IJ. Structural remodeling and mechanical function in heart failure. Microsc Microanal. 2012;18(1):50.
   PubMed Web of Science ®Google Scholar
• Blanchard C, Rothenberg ME. Biology of the eosinophil. Adv Immunol. 2009;101:81–121.
   PubMed Web of Science ®Google Scholar
• Toor IS, et al. E Eosinophils have an essential role in cardiac repair following myocardial infarction. Heart. 2017;103(Suppl 5):A152–A152.
   Google Scholar
• Rosenberg A, et al. Management of hepatic artery aneurysm: a case series. Ann Hepato-Biliary-Pancreatic Surg. 2020;24(3):333–338.
   PubMedGoogle Scholar
• Zordoky BN, et al. Acute doxorubicin toxicity differentially alters cytochrome P450 expression and arachidonic acid metabolism in rat kidney and liver. Drug Metab Dispos. 2011;39(8):1440–1450.
   PubMed Web of Science ®Google Scholar
• Marketou ME, et al. Salt-induced effects on microvascular function: a critical factor in hypertension mediated organ damage. J Clin Hypertens. 2019;21(6):749–757.
   Web of Science ®Google Scholar
• Sant’Ana PG, et al. Heart remodeling produced by aortic stenosis promotes cardiomyocyte apoptosis mediated by collagen V imbalance. Pathophysiology. 2018;25(4):373–379.
   PubMedGoogle Scholar
• Huang BS, Leenen FH. The brain renin-angiotensin-aldosterone system: a major mechanism for sympathetic hyperactivity and left ventricular remodeling and dysfunction after myocardial infarction. Curr Heart Fail Rep. 2009;6(2):81–88.
   PubMedGoogle Scholar
• Lang CC, Struthers AD. Targeting the renin–angiotensin–aldosterone system in heart failure. Nat Rev Cardiol. 2013;10(3):125.
   PubMed Web of Science ®Google Scholar
• Wu Q-Q, et al. Mechanisms contributing to cardiac remodelling. Clin Sci. 2017;131(18):2319–2345.
   PubMed Web of Science ®Google Scholar
• Urabe A, et al. Effects of eplerenone and salt intake on left ventricular remodeling after myocardial infarction in rats. Hypertens Res. 2006;29(8):627–634.
   PubMed Web of Science ®Google Scholar